Table 4.
Quality assessment of studies
| Author and year | Population-based cohort |
Exclusion Child C or comorbidities |
Ascertainment of surveillance receipt |
Accounting for non-US imaging |
Length of follow-up | Accounting for lost to follow-up |
|---|---|---|---|---|---|---|
| Davila 2010 | High | Low | High | Low | High | High |
| Kuo 2010 | Low | Low | Low | Low | Low | High |
| Sanyal 2010 | High | Low | High | Low | Low | High |
| Davila 2011 | High | Low | High | Low | High | High |
| Patwardhan 2011 | Low | Low | Low | High | High | High |
| Stroffolini 2011 | Low | Low | High | Low | Low | High |
| Yang 2011 | Low | Low | Low | High | Low | High |
| Singal 2012 | High | Low | High | Low | High | High |
| Fenoglio 2013 | Low | Low | Low | Low | Low | High |
| Singal 2013 | Low | High | High | Low | High | High |
| Palmer 2013 | High | Low | High | High | High | Low |
| Hasani 2014 | Low | Low | Low | Low | Low | High |
| Edenvik 2015 | High | Low | High | Low | Low | High |
| Singal 2015 | High | Low | High | Low | High | Low |
| Thien 2015 | High | Low | High | Low | High | High |
| Van Meer 2015 | Low | Low | Low | High | High | High |
| Mittal 2016 | High | Low | High | High | High | High |
| Signorelli 2016 | Low | Low | Low | Low | High | Low |
| Wang 2016 | Low | Low | Low | High | High | High |
| Aby 2017 | Low | Low | Low | High | High | High |
| Bucci 2017 | Low | Low | Low | Low | High | High |
| Goldberg 2017 | High | Low | High | High | High | High |
| Mancebo 2017 | Low | High | Low | High | High | High |
| Nam 2017 | Low | Low | Low | High | High | High |
| Robinson 2017 | Low | Low | Low | Low | High | High |
| Singal 2017 | High | Low | High | Low | High | High |
| Tran 2018 | Low | Low | Low | High | High | High |
| Yeo 2018 | High | Low | High | High | High | Low |
| Choi 2019 | High | Low | High | Low | High | High |